liothyronine sodium tablet
1 INDICATIONS AND USAGE Liothyronine sodium is an L-triiodothyronine (T3) indicated for: Hypothyroidism: As replacement in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired Hypothyroidism ( 1.1 ) Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression: As an adjunct to surgery and radioiodine therapy in the management of well-differentiated thyroid cancer ( 1.2 ) Thyroid Suppression Test: As a diagnostic agent in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy ( 1.3 ) Limitations of Use: - Not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients. ( 1 ) - Not indicated for treatment of Hypothyroidism during the recovery phase of subacute thyroiditis. ( 1 ) 1.1 Hypothyroidism Liothyronine Sodium Tablets, USP are indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired Hypothyroidism. 1.2 Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression Liothyronine Sodium Tablets, USP are indicated as an adjunct to surgery and radioiodine therapy in the management of well-differentiated thyroid cancer. 1.3 Thyroid Suppression Test Liothyronine Sodium Tablets, USP are indicated as a diagnostic agent in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy. Limitations of Use Liothyronine Sodium Tablets, USP are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with Liothyronine Sodium Tablets, USP may induce hyperthyroidism [see Warnings and Precautions (5.4) ]. Liothyronine Sodium Tablets, USP are not indicated for treatment of Hypothyroidism during the recovery phase of subacute thyroiditis.
sigmapharm laboratories, llc
ROUND WHITE E 18
E 18 ROUND WHITE
Related Pills
liothyronine sodium tablet
sigmapharm laboratories, llc
liothyronine sodium tablet
sigmapharm laboratories, llc
liothyronine sodium tablet
sigmapharm laboratories, llc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
LIOTHYRONINE SODIUM Tablets, USP (white to off-white, round, SC) are supplied as follows: Strength Tablet Markings NDC 5 mcg debossed “Σ” on one side and “18” on the other side 30 count - 42794-018-08 60 count - 42794-018-10 90 count - 42794-018-12 100 count - 42794-018-02 1000 count - 42794-018-06 25 mcg debossed “Σ19” on one side and “bisectED” on the other side 30 count - 42794-019-08 60 count - 42794-019-10 90 count - 42794-019-12 100 count - 42794-019-02 1000 count - 42794-019-06 50 mcg debossed “Σ20” on one side and “bisectED” on the other side 30 count - 42794-020-08 60 count - 42794-020-10 90 count - 42794-020-12 100 count - 42794-020-02 1000 count - 42794-020-06 Store between 15°C and 30°C (59°F and 86°F).
More pills like ROUND E 18